Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.
Pfizer is deeply unloved, and for good reason, but don't count this drug maker out just yet.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.